Buckhead Capital Management LLC Raises Holdings in The Cooper Companies, Inc. $COO

Buckhead Capital Management LLC lifted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 14.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 58,930 shares of the medical device company’s stock after purchasing an additional 7,368 shares during the period. Cooper Companies comprises approximately 1.5% of Buckhead Capital Management LLC’s portfolio, making the stock its 27th biggest holding. Buckhead Capital Management LLC’s holdings in Cooper Companies were worth $4,040,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of Cooper Companies by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company’s stock worth $1,725,963,000 after buying an additional 421,423 shares during the last quarter. State Street Corp raised its stake in Cooper Companies by 1.2% during the second quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock valued at $616,227,000 after buying an additional 104,910 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Cooper Companies by 2.5% in the 2nd quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company’s stock worth $368,893,000 after purchasing an additional 127,907 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Cooper Companies by 17.0% in the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock worth $399,340,000 after buying an additional 686,751 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in Cooper Companies by 12.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company’s stock valued at $333,595,000 after acquiring an additional 425,400 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Holly R. Sheffield purchased 1,230 shares of the business’s stock in a transaction dated Tuesday, December 16th. The shares were purchased at an average price of $80.75 per share, for a total transaction of $99,322.50. Following the completion of the purchase, the insider owned 39,052 shares in the company, valued at approximately $3,153,449. This represents a 3.25% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Lawrence Erik Kurzius purchased 2,000 shares of Cooper Companies stock in a transaction dated Wednesday, December 17th. The stock was acquired at an average price of $82.50 per share, with a total value of $165,000.00. Following the acquisition, the director owned 7,777 shares in the company, valued at approximately $641,602.50. This represents a 34.62% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 15,230 shares of company stock worth $1,209,103 in the last three months. Corporate insiders own 1.98% of the company’s stock.

Analyst Ratings Changes

COO has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. raised their price target on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a report on Friday, December 5th. Citigroup restated a “neutral” rating and issued a $88.00 price target (up previously from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. Wells Fargo & Company raised their price objective on shares of Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research report on Friday, December 5th. Weiss Ratings reissued a “sell (d+)” rating on shares of Cooper Companies in a research note on Monday. Finally, KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $90.15.

Cooper Companies Price Performance

COO stock opened at $82.46 on Friday. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $100.24. The company has a 50-day moving average price of $74.41 and a 200 day moving average price of $71.89. The stock has a market cap of $16.16 billion, a PE ratio of 43.86, a P/E/G ratio of 2.35 and a beta of 1.05. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies declared that its Board of Directors has initiated a share buyback plan on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its stock is undervalued.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.